Simplex Trading, LLC Adaptimmune Therapeutics PLC Transaction History

Simplex Trading, LLC

  • $195 Billion
  • Q3 2025

A detailed history of Simplex Trading, LLC transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Simplex Trading, LLC holds 12,424 shares of ADAP stock, worth $372. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,424
Holding current value
$372
% of portfolio
0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$0.04 - $0.35 $496 - $4,348
12,424 New
12,424 $1,000
Q3 2024

Nov 08, 2024
BUY
$0.92 - $1.39 $967 - $1,462
1,052 New
1,052 $0
Q4 2023

Feb 02, 2024
BUY
$0.43 - $0.79 $129 - $237
300 New
300 $0
Q2 2023

Aug 04, 2023
SELL
$0.9 - $1.51 $3,312 - $5,558
-3,681 Reduced 28.12%
9,408 $8,000
Q1 2023

Apr 27, 2023
BUY
$1.06 - $2.16 $8,464 - $17,247
7,985 Added 156.45%
13,089 $14,000
Q4 2022

Feb 02, 2023
BUY
$1.05 - $2.53 $3,965 - $9,555
3,777 Added 284.63%
5,104 $7,000
Q3 2022

Nov 04, 2022
SELL
$1.06 - $2.41 $12,963 - $29,474
-12,230 Reduced 90.21%
1,327 $1,000
Q2 2022

Aug 03, 2022
BUY
$1.33 - $2.28 $12,162 - $20,850
9,145 Added 207.28%
13,557 $23,000
Q1 2022

May 02, 2022
SELL
$1.73 - $4.06 $8,772 - $20,588
-5,071 Reduced 53.47%
4,412 $9,000
Q4 2021

Feb 23, 2022
SELL
$3.5 - $5.68 $13,587 - $22,049
-3,882 Reduced 29.05%
9,483 $35,000
Q3 2021

Oct 28, 2021
SELL
$3.44 - $6.37 $32,043 - $59,336
-9,315 Reduced 41.07%
13,365 $58,000
Q2 2021

Aug 12, 2021
SELL
$3.86 - $5.78 $44,752 - $67,013
-11,594 Reduced 33.83%
22,680 $96,000
Q1 2021

Apr 26, 2021
BUY
$4.9 - $6.83 $38,553 - $53,738
7,868 Added 29.8%
34,274 $181,000
Q4 2020

Feb 02, 2021
BUY
$4.0 - $9.2 $105,624 - $242,935
26,406 New
26,406 $142,000
Q3 2020

Oct 14, 2020
SELL
$7.66 - $10.78 $13,129 - $18,476
-1,714 Closed
0 $0
Q2 2020

Jul 13, 2020
SELL
$2.58 - $12.1 $3,704 - $17,375
-1,436 Reduced 45.59%
1,714 $17,000
Q1 2020

Apr 29, 2020
BUY
$1.2 - $4.52 $3,780 - $14,237
3,150 New
3,150 $8,000
Q4 2019

Feb 05, 2020
SELL
$0.72 - $1.43 $46 - $92
-65 Closed
0 $0
Q3 2019

Oct 15, 2019
SELL
$1.43 - $3.81 $1,916 - $5,105
-1,340 Reduced 95.37%
65 $0
Q2 2019

Jul 26, 2019
SELL
$3.23 - $5.41 $2,283 - $3,824
-707 Reduced 33.48%
1,405 $5,000
Q1 2019

Apr 18, 2019
BUY
$3.63 - $6.06 $7,666 - $12,798
2,112 New
2,112 $0
Q4 2018

Jan 16, 2019
SELL
$3.76 - $14.16 $32,411 - $122,059
-8,620 Closed
0 $0
Q3 2018

Oct 23, 2018
BUY
$8.27 - $13.56 $3,407 - $5,586
412 Added 5.02%
8,620 $116,000
Q2 2018

Jul 30, 2018
BUY
$10.42 - $13.74 $63,416 - $83,621
6,086 Added 286.8%
8,208 $97,000
Q1 2018

Apr 26, 2018
BUY
$7.1 - $11.56 $15,066 - $24,530
2,122 New
2,122 $23,000
Q4 2017

Jan 10, 2018
SELL
$6.68 - $8.74 $581 - $760
-87 Closed
0 $0
Q3 2017

Oct 25, 2017
BUY
$4.93 - $8.93 $428 - $776
87
87 $0

Others Institutions Holding ADAP

# of Institutions
56
Shares Held
35.1M
Call Options Held
139K
Put Options Held
144K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $4.9M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email